Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 126 Records) |
| Query Trace: Thrombosis and CYP2C19[original query] |
|---|
| Prevalence of CYP2C19 and ITGB3 polymorphisms among Bangladeshi patients who underwent percutaneous coronary intervention. SAGE open medicine 2021 9 9 20503121211042209. Islam Md Rabiul, Nova Tasnova Tasnim, Momenuzzaman Nam, Rabbi Sikder Nahidul Islam, Jahan Ishrat, Binder Thomas, Islam Mohammad Safiqul, Hasnat Abul, Nahar Zab |
| Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients. International journal of cardiology 2021 Sep . Al-Rubaish Abdullah M, Al-Muhanna Fahad A, Alshehri Abdullah M, Al-Mansori Mohammed A, Alali Rudaynah A, Khalil Rania M, Al-Faraidy Khalid A, Cyrus Cyril, Sulieman Mohammed M, Vatte Chittibabu, Loza Bao-Li, Claassens Daniel M F, Asselbergs Folkert W, Al-Ali Amein |
| Profiling of warfarin pharmacokinetics-associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics-dosing algorithm. Journal of thrombosis and haemostasis : JTH 2021 Aug . Ndadza Arinao, Muyambo Sarudzai, Mntla Pindile, Wonkam Ambroise, Chimusa Emile, Kengne Andre P, Ntsekhe Mpiko, Dandara Coll |
| Effects of aging on clinical outcomes in patients receiving genotype-guided P2Y12 inhibitor selection after percutaneous coronary intervention. Pharmacotherapy 2021 Jul . Wood Brian, Lee Craig R, Mulrenin Ian R, Gower Megan N, Rossi Joseph S, Weck Karen E, Stouffer George |
| Incidence of Device-Related Thrombosis in Watchman Patients Undergoing a Genotype-Guided Antithrombotic Strategy. JACC. Clinical electrophysiology 2021 7 7 (12): 1533-1543. Della Rocca Domenico G, Horton Rodney P, Di Biase Luigi, Gianni Carola, Trivedi Chintan, Mohanty Sanghamitra, Anannab Alisara, Magnocavallo Michele, Chen Qiong, Tarantino Nicola, Bassiouny Mohamed, Lavalle Carlo, Natale Veronica N, Forleo Giovanni B, Del Prete Armando, Van Niekerk Christoffel Johannes, Al-Ahmad Amin, Burkhardt J David, Gallinghouse G Joseph, Sanchez Javier E, Lakkireddy Dhanunjaya, Gibson Douglas N, Natale Andr |
| Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y Inhibitor Therapy: A Meta-Analysis. JACC. Cardiovascular interventions 2021 Apr 14 (7): 739-750. Pereira Naveen L, Rihal Charanjit, Lennon Ryan, Marcus Gil, Shrivastava Sanskriti, Bell Malcolm R, So Derek, Geller Nancy, Goodman Shaun G, Hasan Ahmed, Lerman Amir, Rosenberg Yves, Bailey Kent, Murad M Hassan, Farkouh Michael |
| Association between CYP2C19 polymorphisms and clinical outcomes in patients undergoing stent procedure for cerebral artery stenosis. Scientific reports 2021 Mar 11 (1): 5974. Li Yan-Jiao, Chen Xuan, Tao Li-Na, Hu Xin-Yuan, Wang Xin-Lu, Song Yan-Qi |
| Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients. Aging 2021 Mar 13 (5): 6506-6524. Cha Jung-Joon, Park Jae Hyoung, Joo Hyung Joon, Hong Soon Jun, Ahn Tae Hoon, Kim Byeong-Keuk, Shin WonYong, Ahn Sung Gyun, Yoon JungHan, Kim Yong Hoon, Cho Yun-Hyeong, Kang Woong Chol, Kim Weon, Lim Young-Hyo, Gwon Hyeon Cheol, Choi Woong Gil, Lim Do-S |
| Short- and long-term cost-effectiveness analysis of CYP2C19 genotype-guided therapy, universal clopidogrel, versus universal ticagrelor in post-percutaneous coronary intervention patients in Qatar. International journal of cardiology 2021 2 331 27-34. AlMukdad Sawsan, Elewa Hazem, Arafa Salaheddin, Al-Badriyeh Dao |
| Clinical and Pharmacological Parameters Determine Relapse During Clopidogrel Treatment of Acute Coronary Syndrome. Journal of clinical pharmacology 2021 12 62 (6): 783-791. Santana-Mateos Marta, Medina-Gil José M, Saavedra-Santana Pedro, Martínez-Quintana Efrén, Rodríguez-González Fayna, Tugores Anton |
| Clinical Outcomes After Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms. Journal of cardiovascular pharmacology 2021 Oct . Zhang Yang, Zhao Xiliang, Ye Yicong, Li Quan, Zeng Yo |
| Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in China. European journal of clinical pharmacology 2021 10 78 (2): 215-225. Lyu Si-Qi, Zhu Jun, Wang Juan, Wu Shuang, Zhang Han, Shao Xing-Hui, Yang Yan-M |
| CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD). American heart journal 2022 8 254 141-148. Kranendonk J, Willems L H, Vijver-Coppen Rj van der, Coenen M, Adang E, Donders R, Zeebregts C J, Deneer Vhm, Reijnen Mmpj, Kramers C, Warlé M |
| Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial. Journal of the American Heart Association 2022 6 11 (12): e024709. Madan Mina, Abbott J Dawn, Lennon Ryan, So Derek Y F, MacDougall Andrea M, McLaughlin Mary Ann, Murthy Vishakantha, Saw Jacqueline, Rihal Charanjit, Farkouh Michael E, Pereira Naveen L, Goodman Shaun G, |
| High-Dose Clopidogrel versus Ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: A Meta-Analysis of Randomized Trials. Journal of clinical pharmacy and therapeutics 2022 4 47 (8): 1112-1121. Sheng Xiao-Yan, An Hui-Jie, He Yong-Yang, Ye Yong-Feng, Zhao Jia-Lan, Li S |
| Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation. Clinical pharmacology and therapeutics 2022 4 112 (1): 146-155. Thomas Cameron D, Franchi Francesco, Keeley Ellen C, Rossi Joseph S, Winget Marshall, David Anderson R, Dempsey Alyssa L, Gong Yan, Gower Megan N, Kerensky Richard A, Kulick Natasha, Malave Jean G, McDonough Caitrin W, Mulrenin Ian R, Starostik Petr, Beitelshees Amber L, Johnson Julie A, Stouffer George A, Winterstein Almut G, Angiolillo Dominick J, Lee Craig R, Cavallari Larisa |
| Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis. BMC cardiovascular disorders 2022 3 22 (1): 111. Xie Qiufen, Xiang Qian, Liu Zhiyan, Mu Guangyan, Zhou Shuang, Zhang Zhuo, Ma Lingyue, Gong Yanjun, Jiang Jie, Cui Yim |
| CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. Journal of the American Heart Association 2022 2 11 (4): e024159. Beitelshees Amber L, Thomas Cameron D, Empey Philip E, Stouffer George A, Angiolillo Dominick J, Franchi Francesco, Tuteja Sony, Limdi Nita A, Lee James C, Duarte Julio D, Kreutz Rolf P, Skaar Todd C, Coons James C, Giri Jay, McDonough Caitrin W, Rowland Rachel, Stevenson James M, Thai Thuy, Vesely Mark R, Wellen Jacob T, Johnson Julie A, Winterstein Almut G, Cavallari Larisa H, Lee Craig R, |
| Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Cardiovascular drugs and therapy 2022 11 . Mathew Roy O, Sidhu Mandeep S, Rihal Charanjit S, Lennon Ryan, El-Hajjar Mohammed, Yager Neil, Lyubarova Radmila, Abdul-Nour Khaled, Weitz Steven, O'Cochlain D Fearghas, Murthy Vishakantha, Levisay Justin, Marzo Kevin, Graham John, Dzavik Vlad, So Derek, Goodman Shaun, Rosenberg Yves D, Pereira Naveen, Farkouh Michael |
| COX-1, COX-2 and CYP2C19 variations may be related to cardiovascular events due to acetylsalicylic acid resistance. Molecular biology reports 2022 1 49 (4): 3007-3014. Kirac Deniz, Yaman Aysun Erdem, Doran Tansu, Mihmanli Mujgan, Keles Elif Cigd |
| Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Cardiovascular revascularization medicine : including molecular interventions 2022 1 41 115-121. Malik Aaqib H, Gupta Rahul, Chakraborty Sandipan, Mahajan Pranav, Bandyopadhyay Dhrubajyoti, Yandrapalli Srikanth, Zaid Syed, Sreenivasan Jayakumar, Chaturvedi Abhishek, Mehta Sanjay S, Vyas Apurva V, Patel Nainesh C, Combs William G, Ahmad Has |
| Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention. JACC. Cardiovascular interventions 2023 4 16 (7): 829-843. Lee Seung Hun, Jeong Young-Hoon, Hong David, Choi Ki Hong, Lee Joo Myung, Park Taek Kyu, Yang Jeong Hoon, Hahn Joo-Yong, Choi Seung-Hyuck, Gwon Hyeon-Cheol, Jeong Myung Ho, Kim Byeong-Keuk, Joo Hyung Joon, Chang Kiyuk, Park Yongwhi, Ahn Sung Gyun, Suh Jung-Won, Lee Sang Yeub, Cho Jung Rae, Her Ae-Young, Kim Hyo-Soo, Kim Moo Hyun, Lim Do-Sun, Shin Eun-Seok, Song Young Bin, |
| Cytochrome P450 2C19 Polymorphisms and Its Association With Major Adverse Cardiac Events in Post-coronary Intervention Patients on Clopidogrel in the Tertiary Care Center. Cureus 2023 3 15 (2): e34737. Kambhampati Nikhil Teja, Ahamed Hisham, K K Velayudhan, David Sachin, Hakeem Sai Chandra, Pillai Gopalakrishna, Kartha Nivedit |
| Investigation of genomic and transcriptomic risk factors in clopidogrel response in African Americans. medRxiv : the preprint server for health sciences 2023 12 . Guang Yang, Cristina Alarcon, Catherine Chanfreau, Norman H Lee, Paula Friedman, Edith Nutescu, Matthew Tuck, Travis O'Brien, Li Gong, Teri E Klein, Kyong-Mi Chang, Philip S Tsao, David O Meltzer, , Sony Tuteja, Minoli A Pere |
| Impact of CYP2C19 Genotype Status on Clinical Outcomes in Patients with Symptomatic Coronary Artery Disease, Stroke, and Peripheral Arterial Disease: A Systematic Review and Meta-Analysis. Drugs 2024 9 . Dominique P M S M Maas, Loes H Willems, Josephine Kranendonk, Cornelis Kramers, Michiel C War |
| Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation. BMC medicine 2024 8 22 (1): 335. Ju Hyeon Kim, Soon Jun Hong, Jung-Joon Cha, Subin Lim, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Tae Hoon Ahn, Young-Hoon Jeong, Byeong-Keuk Kim, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Jung-Won Suh, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Hyo-Soo Kim, Moo Hyun Kim, Eun-Seok Shin, Do-Sun L |
| Can CYP2C19 genotyping improve antiplatelet therapy efficacy in real-life practice? Recent advances. Kardiologia polska 2024 8 . Udaya S Tantry, Sahib Singh, Lekshmi Narayan Raghavakurup, Kevin P Bliden, Paul A Gurb |
| Clopidogrel resistance and its effect on clinical outcomes in acute coronary syndrome. Indian heart journal 2024 7 . Heemanshu Lodhi, Keshavamurthy Ganapathy Bhat, Vivek Singh Guleria, Ratheesh Kumar Janardhana Pillai, Ribhu Goel, Nitin Sharma, Anuka Sharma, Varun Shar |
| Analysis of the effect of CYP2C19 gene properties on the anti-platelet aggregation of clopidogrel after carotid artery stenting under network pharmacology. BMC pharmacology & toxicology 2024 6 25 (1): 34. Pengfei Li, Mengying Cao, Ling Liu, Long Chen, Shuang Liang, Youbin Wa |
| Prognostic Impact of CYP2C19 Genotypes on Long-Term Clinical Outcomes in Older Patients After Percutaneous Coronary Intervention. Journal of the American Heart Association 2024 5 13 (10): e032248. Ju Hyeon Kim, Seung-Jun Lee, Jung-Joon Cha, Jae Hyoung Park, Soon Jun Hong, Tae Hoon Ahn, Byeong-Keuk Kim, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Jung-Won Suh, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Young-Hoon Jeong, Hyo-Soo Kim, Moo Hyun Kim, Eun-Seok Shin, Do-Sun Lim, |
- Page last reviewed:Feb 1, 2024
- Content source: